» Articles » PMID: 20890045

Proapoptotic Rassf1A/Mst1 Signaling in Cardiac Fibroblasts is Protective Against Pressure Overload in Mice

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2010 Oct 5
PMID 20890045
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian sterile 20-like kinase 1 (Mst1) is a mammalian homolog of Drosophila Hippo, the master regulator of cell death, proliferation, and organ size in flies. It is the chief component of the mammalian Hippo pathway and promotes apoptosis and inhibits compensatory cardiac hypertrophy, playing a critical role in mediating heart failure. How Mst1 is regulated, however, remains unclear. Using genetically altered mice in which expression of the tumor suppressor Ras-association domain family 1 isoform A (Rassf1A) was modulated in a cell type-specific manner, we demonstrate here that Rassf1A is an endogenous activator of Mst1 in the heart. Although the Rassf1A/Mst1 pathway promoted apoptosis in cardiomyocytes, thereby playing a detrimental role, the same pathway surprisingly inhibited fibroblast proliferation and cardiac hypertrophy through both cell-autonomous and autocrine/paracrine mechanisms, playing a protective role during pressure overload. In cardiac fibroblasts, the Rassf1A/Mst1 pathway negatively regulated TNF-α, a key mediator of hypertrophy, fibrosis, and resulting cardiac dysfunction. These results suggest that the functional consequence of activating the proapoptotic Rassf1A/Mst1 pathway during pressure overload is cell type dependent in the heart and that suppressing this mechanism in cardiac fibroblasts could be detrimental.

Citing Articles

Mst1-mediated phosphorylation of FoxO1 and C/EBP-β stimulates cell-protective mechanisms in cardiomyocytes.

Maejima Y, Nah J, Aryan Z, Zhai P, Sung E, Liu T Nat Commun. 2024; 15(1):6279.

PMID: 39060225 PMC: 11282193. DOI: 10.1038/s41467-024-50393-y.


The relationship between the Hippo signaling pathway and bone metastasis of breast cancer.

Han Q, Qiu S, Hu H, Li W, Dang X, Li X Front Oncol. 2023; 13:1188310.

PMID: 37256184 PMC: 10225633. DOI: 10.3389/fonc.2023.1188310.


The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy.

Yin Y, Tan M, Han L, Zhang L, Zhang Y, Zhang J Acta Pharm Sin B. 2023; 13(5):1956-1975.

PMID: 37250161 PMC: 10213817. DOI: 10.1016/j.apsb.2023.01.015.


Suppression of myeloid YAP antagonizes adverse cardiac remodeling during pressure overload stress.

Francisco J, Guan J, Zhang Y, Nakada Y, Mareedu S, Sung E J Mol Cell Cardiol. 2023; 181:1-14.

PMID: 37235928 PMC: 10524516. DOI: 10.1016/j.yjmcc.2023.05.004.


Hippo-Yap signaling in cardiac and fibrotic remodeling.

Del Re D Curr Opin Physiol. 2023; 26.

PMID: 36644337 PMC: 9836231. DOI: 10.1016/j.cophys.2022.100492.


References
1.
Sadoshima J, Izumo S . Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res. 1993; 73(3):413-23. DOI: 10.1161/01.res.73.3.413. View

2.
Radu M, Chernoff J . The DeMSTification of mammalian Ste20 kinases. Curr Biol. 2009; 19(10):R421-5. DOI: 10.1016/j.cub.2009.04.022. View

3.
Matsui Y, Nakano N, Shao D, Gao S, Luo W, Hong C . Lats2 is a negative regulator of myocyte size in the heart. Circ Res. 2008; 103(11):1309-18. PMC: 2775813. DOI: 10.1161/CIRCRESAHA.108.180042. View

4.
Harvey K, Pfleger C, Hariharan I . The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell. 2003; 114(4):457-67. DOI: 10.1016/s0092-8674(03)00557-9. View

5.
van der Weyden L, Adams D . The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta. 2007; 1776(1):58-85. PMC: 2586335. DOI: 10.1016/j.bbcan.2007.06.003. View